Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roos

Showing results (481-490 of 543) with videos related to

Pageof 55
Sort By:
Virchows Archiv : an International Journal of Pathology|September 3, 2014
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor sizeSandra Steffens, Frederik C Roos, Martin Janssen, et al.
European Journal of Human Genetics : EJHG|January 29, 2015
Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral bloodAnastasios Mastrokolias, Yavuz Ariyurek, Jelle J Goeman, et al.
Human Brain Mapping|March 23, 2012
The structural correlates of functional deficits in early huntington's diseaseChristine Delmaire, Eve M Dumas, Michael A Sharman, et al.
World Journal of Urology|October 26, 2022
Learning curve and functional outcomes after laser enucleation of the prostate for benign prostate hyperplasia according to surgeon's caseloadM Kosiba, B Hoeh, M N Welte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancerErnst J Postema, Pontus K E Börjesson, Wilhelmina C A M Buijs, et al.
Clinical Genitourinary Cancer|August 13, 2020
Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment ModalitiesMarina Deuker, Thomas Martin, Franziska Stolzenbach, et al.
Brain : a Journal of Neurology|May 23, 2018
Testing a longitudinal compensation model in premanifest Huntington's diseaseSarah Gregory, Jeffrey D Long, Stefan Klöppel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinomaPontus K E Börjesson, Ernst J Postema, Jan C Roos, et al.
Journal of the American Heart Association|August 19, 2020
Simultaneous Endo-Epicardial Mapping of the Human Right Atrium: Unraveling Atrial ExcitationRohit K Kharbanda, Paul Knops, Lisette J M E van der Does, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 11, 2002
Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extensionCaroline Brumsen, Socrates E Papapoulos, Paul Lips, et al.
Pageof 55

Showing results (481-490 of 543) with videos related to

Sort By:
Pageof 55
Virchows Archiv : an International Journal of Pathology|September 3, 2014
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor sizeSandra Steffens, Frederik C Roos, Martin Janssen, et al.
European Journal of Human Genetics : EJHG|January 29, 2015
Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral bloodAnastasios Mastrokolias, Yavuz Ariyurek, Jelle J Goeman, et al.
Human Brain Mapping|March 23, 2012
The structural correlates of functional deficits in early huntington's diseaseChristine Delmaire, Eve M Dumas, Michael A Sharman, et al.
World Journal of Urology|October 26, 2022
Learning curve and functional outcomes after laser enucleation of the prostate for benign prostate hyperplasia according to surgeon's caseloadM Kosiba, B Hoeh, M N Welte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancerErnst J Postema, Pontus K E Börjesson, Wilhelmina C A M Buijs, et al.
Clinical Genitourinary Cancer|August 13, 2020
Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment ModalitiesMarina Deuker, Thomas Martin, Franziska Stolzenbach, et al.
Brain : a Journal of Neurology|May 23, 2018
Testing a longitudinal compensation model in premanifest Huntington's diseaseSarah Gregory, Jeffrey D Long, Stefan Klöppel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinomaPontus K E Börjesson, Ernst J Postema, Jan C Roos, et al.
Journal of the American Heart Association|August 19, 2020
Simultaneous Endo-Epicardial Mapping of the Human Right Atrium: Unraveling Atrial ExcitationRohit K Kharbanda, Paul Knops, Lisette J M E van der Does, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 11, 2002
Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extensionCaroline Brumsen, Socrates E Papapoulos, Paul Lips, et al.
Pageof 55